PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PYPD PolyPid Ltd.

Trading 10-05 10:37:27 EDT

5.13

-0.06

-1.16%

High5.33	Low5.11	Vol25.33K
Open5.24	D1 Closing5.19	Amplitude4.24%
Mkt Cap104.20M	Tradable Cap64.19M	Total Shares20.31M
T/O132.62K	T/O Rate0.20%	Tradable Shares12.51M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PYPD","market":"US","secType":"STK","nameCN":"PolyPid Ltd.","latestPrice":5.13,"timestamp":1791210460963,"preClose":5.19,"halted":0,"volume":25328,"delay":0,"changeRate":-0.011560693641618592,"floatShares":12512129,"shares":20311800,"eps":-1.47622,"marketStatus":"Trading","change":-0.06,"latestTime":"10-05 10:37:27 EDT","open":5.235,"high":5.33,"low":5.11,"amount":132617.5194432,"amplitude":0.042389,"askPrice":5.14,"askSize":202,"bidPrice":5.07,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-1.47622,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"listingDate":1593144000000,"exchange":"NASDAQ","adjPreClose":5.19,"preHourTrading":{"tag":"盘前","latestPrice":5.1268,"preClose":5.19,"latestTime":"07:37 EDT","volume":644,"amount":3421.9998736000002,"timestamp":1791200250402,"change":-0.0632,"changeRate":-0.012177,"amplitude":0.095029},"postHourTrading":{"tag":"盘后","latestPrice":5.13,"preClose":5.19,"latestTime":"19:30 EDT","volume":621,"amount":3204.0026,"timestamp":1790983802978,"change":-0.06,"changeRate":-0.011561,"amplitude":0.011561},"volumeRatio":1.524225,"impliedVol":1.1558,"impliedVolPercentile":0.1808},"requestUrl":"/m/hq/s/PYPD/wiki","defaultTab":"wiki","newsList":[{"id":"2672768867","title":"PolyPid’s D-PLEX₁₀₀ Application Validated by EMA, Advancing Dual EU–U.S. Reviews","url":"https://stock-news.laohu8.com/highlight/detail?id=2672768867","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672768867?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:48","pubTimestamp":1790862524,"startTime":"0","endTime":"0","summary":"PolyPid ( ($PYPD) ) has shared an announcement. PolyPid announced on October 1, 2026 that the European Medicines Agency has validated its Marketing...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypids-d-plex-application-validated-by-ema-advancing-dual-eu-u-s-reviews?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypids-d-plex-application-validated-by-ema-advancing-dual-eu-u-s-reviews?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PYPD","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672757745","title":"EMA Validates PolyPid D-Plex100 Marketing Authorization Application, Triggers Formal Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2672757745","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672757745?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860528,"startTime":"0","endTime":"0","summary":"EMA validates PolyPid D-PLEX100 marketing authorization application, triggers formal reviewEMA validated PolyPid’s marketing authorization application for D-PLEX100, triggering a formal review for pre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2SxLN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","IE00B64PRP62.GBP","PYPD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","BK4007","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672757715","title":"European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-Plex₁₀₀","url":"https://stock-news.laohu8.com/highlight/detail?id=2672757715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672757715?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:15","pubTimestamp":1790860500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA7BYCS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672275751","title":"PolyPid - Co and Advanz Pharma Terminate Exclusive European Agreement for D-Plex₁₀₀","url":"https://stock-news.laohu8.com/highlight/detail?id=2672275751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672275751?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:56","pubTimestamp":1790859401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N192:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667640569","title":"PolyPid Announces Participation in Upcoming Fall Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2667640569","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667640569?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:30","pubTimestamp":1789475400,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, Sept.  15, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by e","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362070/0/en/polypid-announces-participation-in-upcoming-fall-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659194260","title":"Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659194260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659194260?lang=en_us&edition=fundamental","pubTime":"2026-08-14 10:30","pubTimestamp":1786674606,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PolyPid (PYPD) and Equillium (EQ) with bullish senti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-polypid-pypd-equillium-eq-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-polypid-pypd-equillium-eq-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4568","EQ","BK4139","PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659018183","title":"PolyPid Earnings Call: Priority Review, Big Azurity Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659018183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659018183?lang=en_us&edition=fundamental","pubTime":"2026-08-13 08:12","pubTimestamp":1786579923,"startTime":"0","endTime":"0","summary":"PolyPid Ltd. (($PYPD)) has held its Q2 earnings call. Read on for the main highlights of the call. PolyPid’s latest earnings call struck an optimis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-earnings-call-priority-review-big-azurity-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-earnings-call-priority-review-big-azurity-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659218328","title":"PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2659218328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659218328?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:17","pubTimestamp":1786569444,"startTime":"0","endTime":"0","summary":"The latest announcement is out from PolyPid ( ($PYPD) ). On August 12, 2026, PolyPid filed a Form 6-K with the U.S. Securities and Exchange Commiss...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-posts-wider-h1-2026-loss-as-assets-and-equity-decline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-posts-wider-h1-2026-loss-as-assets-and-equity-decline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VMRK","BK4585","PYPD","REZ","BK4215","BK4007","EQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659901615","title":"Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659901615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659901615?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:50","pubTimestamp":1786553410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bionano-genomics-bngo-liquidia-technologies-lqda-and-polypid-pypd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","XLV","PYPD","BK4575","LABU","BK4581","BNGO","LU0128526141.USD","LU0029874061.USD","BK4585","BK4588","HCSG","XBI","BK4007","BK4121","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086519","title":"PolyPid Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086519","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086519?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:33","pubTimestamp":1786541580,"startTime":"0","endTime":"0","summary":"PolyPid Ltd reports results for the quarter ended June 30 - Earnings SummaryPolyPid LtdPYPD.OQreported a quarterly adjusted loss of 35 cents per share for the quarter ended June 30, higher than the sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974628","title":"PolyPid Q2 FY26 Net Loss Narrows 22% to $7.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974628","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974628?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:32","pubTimestamp":1786534354,"startTime":"0","endTime":"0","summary":"PolyPid Q2 FY26 net loss narrows 22% to $7.8 millionPolyPid posted a Q2 net loss of $7.8 million, narrowing from a $10 million loss a year earlier; loss per share improved to $(0.35).R&D spending edge","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL36YhYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014039.USD","SG9999014005.SGD","BK4585","BK4588","BK4007","IE00BN0W2V16.EUR","PYPD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014021.USD","NDAQ","LU2095319765.USD","IE00BN0W2W23.USD","BCDF","BK4112","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658746999","title":"PolyPid Q2 EPS $(0.35) Beats $(0.38) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658746999","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658746999?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534241,"startTime":"0","endTime":"0","summary":"PolyPid (NASDAQ:PYPD) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.38) by 7.89 percent. This is a 55.13 percent increase over losses of $(0.78) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61137549/polypid-q2-eps-0-35-beats-0-38-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974901","title":"Press Release: PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974901","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974901?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"-- Completed its New Drug Application  submission to the U.S.Food and Drug Administration  for D-PLEX for the prevention. abdominal colorectal surgery, supported by positive results from. the pivotal Phase 3 SHIELD II trial, which met its primary. endpoint and all key secondary endpoints and demonstrated a 60%. relative risk reduction in SSIs compared to standard of care. -- Subsequent to quarter end, on July 27, 2026, the FDA accepted. D-PLEX NDA submission and granted Priority Review, with a. Prescription Drug User Fee Act  goal date of November 28,communicated first quarter 2027 guidance. The FDA did not identify. any filing review issues in its acceptance communications.-- Exclusive U.S. and Canada Commercialization Partnership with Azurity. -- Following the end of the quarter, on July 17, 2026, PolyPid. entered into a commercial partnership agreement with Azurity. deep experience in specialty and hospital-based therapies with. more than 50 medicines across 10 therapeutic areas. Az","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","03160","BK4588","BK4585","BK4555","BK4604","LABU","PYPD","BK4007","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493435","title":"PolyPid Ltd Expected to Post a Loss of 38 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493435","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493435?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:40","pubTimestamp":1786369210,"startTime":"0","endTime":"0","summary":"PolyPid Ltd <PYPD.OQ> expected to post a loss of38cents a share - Earnings PreviewPolyPid LtdPYPD.OQPYPD.Ois expected to  show no change in quarterly revenue when it reports  results on August 12 for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N447178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655872123","title":"PolyPid to Report Q2 2026 Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872123","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872123?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:10","pubTimestamp":1785413436,"startTime":"0","endTime":"0","summary":"PolyPid to report Q2 2026 results, host conference callPolyPid will report Q2 2026 financial results before the U.S. market open on Aug. 12, 2026.Conference call, webcast scheduled for Aug. 12, 2026 a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDLbQNtgF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NDAQ","BK4007","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","SG9999014005.SGD","BK4112","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","PYPD","SG9999014021.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655724588","title":"PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655724588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655724588?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:00","pubTimestamp":1785412800,"startTime":"0","endTime":"0","summary":"PETACH TIKVA, Israel, July  30, 2026  (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (\"PolyPid\" or the \"Company\"), an innovative biopharmaceutical company dedicated to improving patient outcomes by e","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3335971/0/en/PolyPid-to-Report-Second-Quarter-2026-Financial-Results-and-Operational-Highlights-on-August-12-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PYPD","BK4520","BK4007","X","BK4006","BK4588","BK4585","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655894916","title":"PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2655894916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655894916?lang=en_us&edition=fundamental","pubTime":"2026-07-29 23:30","pubTimestamp":1785339017,"startTime":"0","endTime":"0","summary":"The FDA accepted D-PLEX100’s NDA for priority review, strengthening the regulatory outlook and PolyPid’s (PYPD) balance sheet through a $15M milest...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polypid-nda-acceptance-meets-or-exceeds-expectations-says-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polypid-nda-acceptance-meets-or-exceeds-expectations-says-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD","BK4585","BK4007","LABU","BK4588","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655930893","title":"PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2655930893","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655930893?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:57","pubTimestamp":1785329843,"startTime":"0","endTime":"0","summary":"PolyPid ( ($PYPD) ) just unveiled an announcement. On July 29, 2026, PolyPid announced that the U.S. Food and Drug Administration accepted for fili...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polypid-wins-fda-priority-review-for-d-plex100-nda-accelerating-path-to-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polypid-wins-fda-priority-review-for-d-plex100-nda-accelerating-path-to-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PYPD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804898","title":"PolyPid Says FDA Accepts D-plex100 NDA, Grants Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804898","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804898?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:31","pubTimestamp":1785328299,"startTime":"0","endTime":"0","summary":"PolyPid says FDA accepts D-PLEX100 NDA, grants priority reviewFDA accepted PolyPid’s NDA for D-PLEX100 to prevent surgical-site infections in abdominal colorectal surgery, granting Priority Review.PDU","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL6m9t9t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4112","BK4588","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014039.USD","PYPD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655860025","title":"PolyPid - FDA Sets Pdufa Target Action Date of November 28, 2026 for D-Plex100","url":"https://stock-news.laohu8.com/highlight/detail?id=2655860025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655860025?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:30","pubTimestamp":1785328200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUAC7S8K4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYPD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.polypid.com","stockEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0208},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1822},{"period":"1year","weight":0.5},{"period":"ytd","weight":0.1959}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.080091},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.020861},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.068892},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.012937},{"month":5,"riseRate":0.5,"avgChangeRate":0.007427},{"month":6,"riseRate":0.333333,"avgChangeRate":0.007342},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.087405},{"month":8,"riseRate":0.428571,"avgChangeRate":0.032013},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.225437},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.053135},{"month":11,"riseRate":0.666667,"avgChangeRate":0.027739},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.103805}],"exchange":"NASDAQ","name":"PolyPid Ltd.","nameEN":"PolyPid Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PolyPid Ltd.,PYPD,PolyPid Ltd.股票,PolyPid Ltd.股票老虎,PolyPid Ltd.股票老虎国际,PolyPid Ltd.行情,PolyPid Ltd.股票行情,PolyPid Ltd.股价,PolyPid Ltd.股市,PolyPid Ltd.股票价格,PolyPid Ltd.股票交易,PolyPid Ltd.股票购买,PolyPid Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PolyPid Ltd.(PYPD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PolyPid Ltd.(PYPD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}